1Kyo S, Kanaya T, Takakura M, et al. Expression of human telomerase subunit in ovarian malignant, borderline and benign tumors. Int J Cancer, 1999,80:804-809.
2Oishi T, Kigawa J, Minagawa Y, et al. Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.Obstet Gynecol, 1998,91:568-571.
3Counter CM, Meyerson M, Eaton EN, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT(hKS32), the catalytic subunit of telomerase. Oncogene, 1998,16: 1217-1222.
6Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Research, 1999,59:551-557.
7Marks P, Ritkind RA, Richon VM, et al. llistone deacetylases and cancer: causes and therapies. Nat Rev Cancer, 2001,1 : 194-202.
8Kwon HJ, Kim M, Kim DH. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J Biochem Mol Biol, 2003, 36:110-119.
